VerapamilP031-02 P030-13 Epilepsy, obsessive compulsive disorder, self-mutilation: A case report Mete Saylan, Istanbul University, Medical Faculty, Dept. of Psychiatry, Istanbul, Turkey, Email: msaylan usa D. Kinay, I. n. Kulaksizoglu, B. Baykan, C. Gurses, H. Gurvit, A. Gokyigit Objective: In that paper, our aim is to discuss a case with comorbid severe and recurrent self-mutilative behavior, intractable epilepsy and OCD by the aid of the data obtained in the end of 3 years follow up period. Methods: Two psychiatrists and two neurologists accomplished psychiatric and neurological follow up. Brain SPECT, MRI scans and temporal volumetric analysis were performed. The WADA and a large neuropsychological test battery were carried out before and after the neurosurgical intervention. Results: At 30 years old, he admitted to our psychiatry clinic complaining of worries about his future and his self-mutilative behaviors. He started to have grand mal seizures followed by peevishness and aggressive behaviors at age of 4. He has started knitting at 7 years old and actually he is spending all his time by knitting. In his family history, his father and paternal uncle committed suicides. He has obsessions of pathological doubt, cleanness and compulsion of counting, remembering, and asking about the same subject. He ceases his anxiety and his anger by cutting himself in a very brutal way: like cutting his abdomen by razor blade or nail clippers. He repeated 27 times these self-mutilative behaviors and had many surgical interventions. He has an intractable OCD and epilepsy. Neurological examination revealed a task tremor of the head and the hands. SPECT, MRI and MR spectroscopy analysis showed left temporal sclerosis and left hippocampal atrophy. Serial preoperative long electroencephalographic recordings demonstrated focal epileptic abnormalities arising from left frontotemporal area. The WADA test showed that the patient's language functions locate entirely on the left hemisphere and memory functions are on the right. A selective left amigdalohippocampalectomy operation was performed. The postoperative neuropsychological assessment presented a considerable improvement in the preoperative frontal findings; normalization in the perseverations and in recall difficulties of the visual and verbal memory also is noticed. Seizures and self-mutilative behavior disappeared after the operation. Obsessive-compulsive symptoms also diminished. Conclusions: The manifestation of psychiatric symptoms just after the onset of epileptic seizures is interesting in that patient who had a normal psychomotor development until the age of five. The common origin model is the best one for this case among the different hypothesis to explain behavioral problems that emerged in epileptics. The cases of concomitant OCD and epilepsy are reported in the literature. The density of psychiatric illnesses in the paternal family history may also be discussed as a possible etiological factor. Kooowitz et al tried to explain this co-morbidity in their case reports by hypothesizing that obsessive-compulsive symptoms may be a variant of epileptiform forced thinking and this patients may be classified as a subgroup. In this case, we think that the underlying mesial temporal sclerosis and limbic system damage play an important role in the pathology of the epilepsy and OCD. As there is no data in the literature about how psychiatric disorder is influenced after epilepsy neurosurgery, it is important to continue its follow-up. On account of this case, the importance of cooperation between neurology and psychiatry clinics is revealed. Store verapamil at room temperature away from moisture and heat. P350C TM6 ; G939C TM11 ; and P350C TM6 ; V991C TM12 ; . Their activities were compared to that of mutant P350C parent ; . We previously showed that mutant P350C exhibited high levels of drug-stimulated ATPase activity 11 ; . Fig. 4 shows that the ATPase activities of mutants P350C TM6 ; A935C TM11 ; , P350C TM6 ; G939C TM11 ; and P350C TM6 ; V991C TM12 ; were stimulated by colchicine, demecolcine, progesterone, cis- Z ; -flupenthixol, verapamil or vinblastine. The ATPase activities of the mutants were inhibited by cyclosporin A and trans- Z ; -flupenthixol data not shown ; . This is consistent with previous observations that saturating concentrations of cyclosporin A inhibits P-gp ATPase activity, while the cis- Z ; - and trans- E ; - isomers of flupenthixol stimulate and inhibit respectively, the ATPase activity of P-gp 26, 38, 39 ; . These results indicate that the mutant P-gps can still bind drug substrates. Calcium blockers like verapamil are often also effective in arrthymias and might be a short term answer to see how much is you and how much is the beta blocker. Verapamil available ; verapamil is available in the usa the usual dose is 120 to 240mg, sr, once per day.
Numbness, paresthesias, tiredness and tightening, and heaviness of neck, jaw, and chest. Triptans can narrow coronary arteries. These drugs are contraindicated in coronary artery disease, vascular disease, uncontrolled hypertension, basilar or hemiplegic migraine or within 24 hours of another triptan or ergot. f. Sumatriptan is the most used triptan. The injection has the fastest onset for a triptan, and the highest overall efficacy. Zolmitriptan Zomig ; a. Zolmitriptan has an oral bioavailability of 40%. Zolmitriptan is contraindicated with MAO-A inhibitors. The optimal dose is 2.5 mg. The maximum dose is 10 mg per 24 hours. Two-hour headache response is 62-65%. Recurrence rate averages about 30%. Adverse events are triptan sensations, similar to sumatriptan tablets. b. Zolmitriptan is superior to oral sumatriptan 50 mg ; for headache response at two hours, 67.1% vs. 63.8%, respectively. Zolmitriptan has a longer duration of action than sumatriptan. Naratriptan Amerge ; has good oral bioavailability 63-74% ; and a longer T 1 2 hours ; than sumatriptan. It works more slowly, and in a lower percentage of patients, than the other three triptans. Two-hour headache response for the optimal dose of 2.5 mg is 48%. The maximum dose is 5 mg per 24 hours. Naratriptan should not be used in patients with rapid onset migraine or who wake up with migraine. Naratriptan should only be selected for those patients who are sensitive to side effects. Frovatriptan Frova ; has the longest half-life 26 hours compared to 6 hours or less for the others ; . It has a slow onset and is less effective than the other triptans. Frova comes in 2.5 mg tablets. Patients start with one tablet and can repeat after 2 hours if the headache recurs; maximum 3 tabs in 24 hours. Eletriptan Relpax ; appears to be at least as effective as oral sumatriptan for acute treatment of migraine. Eletriptan interacts with CYP3A4 inhibitors, including verapamil, which is used for migraine prophylaxis. Initial dosage is 20 or mg, which can be repeated after 2 hours if headache improves and then recurs. The maximum dosage is 80 mg in 24 hours. Triptan selection a. Patients with migraine should receive a triptan as the first-line medication. If they have significant nausea, an oral drug is not recommended. Rather, a parenteral or nasal spray sumatriptan should be used. b. Most patients should initially be treated with rizatriptan Maxalt ; or almotriptan Axert ; . Other agents may be used if the patient requires a faster onset, longer duration, or fewer side effects. c. Sumatriptan provides the greatest versatility in multiple forms to allow a patient various modes of treatment. The 6-mg subcutaneous injection offers the greatest speed and the highest efficacy of any triptan. d. Rizatriptan Maxalt ; tends to be faster and more effective than oral sumatriptan with a similar incidence of adverse effects. e. Almotriptan Axert ; seems to work about as well as sumatriptan, but it's better tolerated. f. Zolmitriptan Zomig ; has similar efficacy and tolerability compared to sumatriptan. g. Naratriptan Amerge ; has a slower onset and is less effective, but this agent is better tolerated. h. Frovatriptan Frova ; has the longest half-life 26 hours compared to 6 hours or less for the others ; . It has a slow onset and is less effective than the other triptans and vicoprofen. Relevance: 15 60 * 6 - spam points : -1 type of weblink : 4 id source : 4 hits by anonymous : 0 hits by registered users : 0 time of adding : 01 1970 - almogran 1 5mg tablets , spc f rom the emc almogran 1 5mg tablets , summary o f product characteristics spc ; f rom the emc and wellbutrin. A total of 5 different concentrations of verapam9l were tested. Ventricular function during exercise. At level 2 exercise, when all patients taking placebo had angina and ischemic ST depression, the EF decreased or did not change. In contrast, during therapy with either propranolol or verapamil, when exercise-induced ische and xalatan. Verapamil weaknessNeurotransmitter and other amino acid levels in the CSF of the Senegalese baboon Papio Papio. Brain Res 1991; 538: 15-23. Buggy DJ, Nicol B, Rowbotham DJ, Lambert DG. Effects of intravenous anesthetic agents on glutamate release: a role for GABAA receptor-mediated inhibition Anesthesiology 2000; 92: 1067-1073. Little HJ, Clark A, Watson WP Investigations into pharmacological antagonism of general . anaesthesia Brit J Pharmacol 2000; 129: 1755-1763 Blennow G, Folbergrova J, Nilsson B, Siesjo BK. Cerebral metabolic and circulatory changes in the rat during sustained seizures induced by DL-homocysteine. Brain Res 1979; 179 and xenical. 130 131 132 Sewage and refuse disposal, sanitation and similar activities P 3702 Sewerage and Drainage Services P 109.03 Incineration of hazardous or municipal waste OR P 7.0 WATER - SEWAGE TREATMENT WORKS 80 Education 85 Health and social work OR P 86 Health Services OR OR OR Health and Social Service Industries OR OR P 914 Advanced educational organizations 89 Public health services 88 Medical and other health services 383 Collection, purification and distribution of water, and sewage collection, processing and disposal 8716 Domestic waste treatment services 872 Industrial waste treatment services OR OR OR, because verapamil sa. Figure 3. Stable expression of CD44s in MCF-7 cells promotes the MDR phenotype by inducing the expression of MDR1. A, immunoblotting. Cell lysates from MCF-7 vector negative control ; and MCF-7 CD44s stable transfectants were immunoblotted with anti-P-glycoprotein P-gp ; or anti-CD44s antibody a ; . An anti-tubulin antibody immunoblotting was used as a loading control. Cell lysates from MCF-7 BC19 vector negative control ; and MCF-7 BC19 CD44s stable transfectants were analyzed as in a but using h-actin immunoblotting as loading control b ; . B, immunoprecipitation. MCF-7 CD44s cell lysate was immunoprecipitated with anti-P-glycoprotein antibody and immunoblotted with anti-CD44s antibody. Cell lysates from MCF-7 BC19 P-glycoprotein positive, CD44s negative ; and MCF-7 P-glycoprotein and CD44s negative ; were used as experimental negative controls. C, cell migration analysis. MCF-7 AdrR and MCF-7 BC19 CD44s clone 12 were seeded in in vitro migration inserts in the presence or absence of vinblastine or tFPT. After 48 hours, the cells that migrated to the other side of the membrane were fixed, stained, and counted. Percentage of migration is based on the number of migrating MCF-7 Adr cells. Three wells per cell line were analyzed. D, drug accumulation assay. MCF-7 CD44s and MCF-7 cells were incubated in the presence or absence of verapamil and treated with tritium-labeled Taxol for 3 hours and the Taxol uptake was quantified in a scintillation counter and zestoretic. Corman B: Effect of chronic converting-enzyme Inhibition on kidney function of senescent hypertensive rats. J Cardiovasc Pharmacol 1994; 23: S19-S25. Carmines PK, Navar LG: Disparate effects of a Ca channel blockade on afferent and efferent arteriolar responses to angiotensin II. J Physiol 1989; 256: F1015-F1020. Harris DCH, Hammond WS, Burke TJ, Schrier RW: Verqpamil protects against progression of experimental chronic renal failure. Kidney mt 1987; 3 1: ter Wee PM, Dc Michei AG, Epstein M: Effects of calcium antagonists on renal hemodynamics and progression of nondiabetic chronic renal disease. Arch Intern Med 1994; 154: 1185-1202. Wenzel UO, Hehmchen U, Schoeppe W, Schwietzer 0: Combination treatment of enalapril with nitrendipine in rats with renovascular hypertension. Hypertension. On a side note: verapamil has been used in clinical trials to see it's effectiveness and zestril. Hydrochlorothiazide Continued ; Nifedipine: Enhanced hypotensive effect Nitrous oxide: Enhanced hypotensive effect * Prazosin: Enhanced hypotensive effect; increased risk of first-dose hypotensive effect of prazosin Prednisolone: Antagonism of diuretic effect; increased risk of hypokalaemia Propranolol: Enhanced hypotensive effect * Quinidine: Cardiac toxicity of quinidine increased if hypokalaemia occurs Reserpine: Enhanced hypotensive effect Salbutamol: Increased risk of hypokalaemia with high doses of salbutamol Sodium nitroprusside: Enhanced hypotensive effect Theophylline: Increased risk of hypokalaemia Thiopental: Enhanced hypotensive effect Timolol: Enhanced hypotensive effect Verapamil: Enhanced hypotensive effect Hydrocortisone NOTE. Interactions do not generally apply to hydrocortisone used for topical application Acetazolamide: Increased risk of hypokalaemia; antagonism of diuretic effect Acetylsalicylic acid: Increased risk of gastrointestinal bleeding and ulceration; hydrocortisone reduces plasma-salicylate concentration Amiloride: Antagonism of diuretic effect * Amphotericin: Increased risk of hypokalaemia avoid concomitant use unless hydrocortisone needed to control reactions ; Atenolol: Antagonism of hypotensive effect Captopril: Antagonism of hypotensive effect * Carbamazepine: Accelerated metabolism of hydrocortisone reduced effect ; Contraceptives, Oral: Oral contraceptives increase plasma concentration of hydrocortisone Digoxin: Increased risk of hypokalaemia Erythromycin: Erythromycin possibly inhibits metabolism of hydrocortisone Furosemide: Antagonism of diuretic effect; increased risk of hypokalaemia Glibenclamide: Antagonism of hypoglycaemic effect Glyceryl trinitrate: Antagonism of hypotensive effect Hydralazine: Antagonism of hypotensive effect Hydrochlorothiazide: Antagonism of diuretic effect; increased risk of hypokalaemia Ibuprofen: Increased risk of gastrointestinal bleeding and ulceration Insulins: Antagonism of hypoglycaemic effect Isosorbide dinitrate: Antagonism of hypotensive effect Levonorgestrel: Levonorgestrel increases plasma concentration of hydrocortisone Medroxyprogesterone: Medroxyprogesterone increases plasma concentration of hydrocortisone Metformin: Antagonism of hypoglycaemic effect Methotrexate: Increased risk of haematological toxicity Methyldopa: Antagonism of hypotensive effect Nifedipine: Antagonism of hypotensive effect Norethisterone: Norethisterone increases plasma concentration of hydrocortisone * Phenobarbital: Metabolism of hydrocortisone accelerated reduced effect ; * Phenytoin: Metabolism of hydrocortisone accelerated reduced effect ; Prazosin: Antagonism of hypotensive effect Propranolol: Antagonism of hypotensive effect Reserpine: Antagonism of hypotensive effect * Rifampicin: Accelerated metabolism of hydrocortisone reduced effect ; Ritonavir: Plasma concentration possibly increased by ritonavir. This can be largely avoided by co-administration of digoxin lanoxin ; or verapamil and ziac and verapamil. Verapamil migraine prophylaxisPokemon yellow version cheats, rythmol irregular heartbeats, lysodren testing, toddler xmas crafts and thioridazine retinal toxicity. Levonorgestrel bp, uvula growing, laparoscopy dye test and wisdom tooth kim jung eun or gastroenterology and hepatology journal. Verapamil ointmentVerapamil weakness, verapamil migraine prophylaxis, verapamil ointment, verapamil more medical_authorities and verapamil pravastatin interaction. Verapam9l keloids, verapamil chf, verapamil gingival hyperplasia and verapamil brand or verapamil sa 240mg. Copyright © 2009 by Allcheap.tripod.com Inc.
|
|
Advair Ovral Bactrim Rimonabant |